Cargando…
Corrigendum: Effect of a Topical Nonsteroidal Anti-Inflammatory Drug (0.1% Pranoprofen) on VEGF and COX-2 Expression in Primary Pterygium
Autores principales: | Yao, Bangtao, Wang, Fei, Zhao, Xiaogui, Wang, Bei, Yue, Xiaoli, Ding, Yuhua, Liu, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415084/ https://www.ncbi.nlm.nih.gov/pubmed/34483947 http://dx.doi.org/10.3389/fphar.2021.743733 |
Ejemplares similares
-
Effect of a Topical Nonsteroidal Anti-Inflammatory Drug (0.1% Pranoprofen) on VEGF and COX-2 Expression in Primary Pterygium
por: Yao, Bangtao, et al.
Publicado: (2021) -
The necessity of pretreatment with 0.1% pranoprofen for femtosecond-assisted cataract surgery: A single-center, randomized controlled trial
por: Geng, Zhao, et al.
Publicado: (2023) -
Effects of Pranoprofen on Aqueous Humor Monocyte Chemoattractant Protein-1 Level and Pain Relief During Second-Eye Cataract Surgery
por: Zhang, Yinglei, et al.
Publicado: (2018) -
Optical coherence tomography angiography findings of choroidal neovascularization secondary to decalcified choroidal osteoma treated with intravitreal aflibercept: A case report
por: Yao, Bangtao, et al.
Publicado: (2020) -
Clinical Characteristics and Prognosis of Adult Orbital Cellulitis in a Tertiary General Hospital
por: Yao, Bangtao, et al.
Publicado: (2020)